Members' Choice Award
Each year, the Headache® Journal Editorial Board invites the members of the American Headache Society to vote for one standout piece published in the journal from the previous year. The nominated articles are selected by the journal’s Editor-in-Chief, Amy Gelfand, MD, FAHS, and represent the most impactful work published over the previous 12 months.
The selected paper will be announced in the July-August issue of Headache and at the Annual Scientific Meeting. The authors of the winning paper will be notified ahead of time and asked to contribute an editorial discussing their work.
Beginning March 1, AHS members in good standing should log into their member account and click on the “Membership” tab to access the ballot and cast their vote. Voting will be open through Monday, March 31 at 11:59 PM ET.
Candidates for the best article published in Headache® in 2024 are as follows:
- Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study (Maggie R. MIttleman BA, Elizabeth Mostofsky ScD, Angeliki Vgontzas MD, Suxanne M. Bertisch MD, MPH)
- Anxiety and depressive symptoms and migraine-related outcomes in children and adolescents (Bilal Ahmed Rizvi BSc, Jonathan Kuziek MSc, Lydia Y. Cho BSc, MSc, Paul E. Ronksley PhD, Melanie N. Noel PhD, Serena Laura Orr MD, MSc)
- Prevalence and burden of migraine in the United States: A systematic review (Fred Cohen MD, Caroline V. Brooks MA, Daniel Sun BS, Dawn C. Buse PhD, Michael L. Reed PhD, Kristina M. Fanning PhD, Richard B. Lipton MD)
- Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine (Jessica Ailani MD, Pranav Gandhi PhD, Anjana Lalla MS, Rashmi Halker Singh MD, Peter McAllister MD, Jonathan H. Smith MD, Brett Dabruzzo PharmD, Natty Chalermpalanupap PhD, Kari Kelton PhD, Stephanie J. Nahas MD)
- A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study (Jeffrey D. Sharon MD, Roseanne Krauter FNP, Ricky Chae BA, Adam Gardi BS, Maxwell Hum BS, Isabel Allen PhD, Morris Levin MD)
Past Recipients
2024 - Aura phenomena do not initiate migraine attacks—Findings from neuroimaging
(Jan Mehnert, Laura Fischer-Schulte, Arne May MD, PhD)
2023 – The unique role of stigma in migraine-related disability and quality of life
(Elizabeth K. Seng PhD, Robert E. Shapiro MD, PhD, Dawn C. Buse PhD, Matthew S. Robbins MD, Richard B. Lipton MD, Amanda Parker PhD)
2022 – Management of primary headaches during pregnancy, postpartum, and breastfeeding: A systematic review (Ian J. Saldanha MBBS, MPH, PhD, Wangnan Cao PhD, Monika Reddy Bhuma BDS, MPH, Kristin J. Konnyu PhD, Gaelen P. Adam MLIS, MPH, Shivani Mehta BA, Andrew R. Zullo PharmD, PhD, Kenneth K. Chen MD, Julie L. Roth MD, Ethan M. Balk MD, MPH)
2021 – Alterations in Brain Function After Cognitive Behavioral Therapy for Migraine in Children and Adolescents (Hadas Nahman-Averbuch PhD, Victor J. Schneider II BSc, Leigh Ann Chamberlin RD, Med, Ashley M. Kroon Van Diest PhD, James L. Peugh PhD, Gregory R. Lee PhD, Rupa Radhakrishnan MD, MS, Andrew D. Hershey MD, PhD, FAHS, Christopher D. King PhD, Robert C. Coghill PhD, Scott W. Powers PhD, ABPP, FAHS)
2020 – Eleven Things Not to Say to Your Female Colleagues (Clarimar Borrero-Mejias; Amaal J. Starling; Rebecca Burch; Elizabeth Loder)
2019 – Spontaneous Intracranial Hypotension: 10 Myths and Misperceptions (Peter G. Kranz, Linda Gray, Timothy J. Amrhein)
Migraine Progression: A Systematic Review (Dawn C. Buse, Jacob D. Greisman, Khosrow Baigi and Richard B. Lipton)
2018 – Headache in Idiopathic Intracranial Hypertension: Findings From the Idiopathic Intracranial Hypertension Treatment Trial (Deborah I Friedman, Peter A. Quiros, Prem S. Subramanian, Luis J. Mejico, Shan Gao, Michael McDermott, Michael Wall)
2017 – Functional Neuroimaging in Migraine: Chances and Challenges (Laura H. Schulte and Arne May)
The Role of Melatonin in the Treatment of Primary Headache Disorders (Amy Gelfand and Peter J. Goadsby)
2016 – Adding Additional Acute Medications to a Triptan Regiment for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study (Dawn Buse, Daniel Serrano, Michael Reed, Shashi h. Kori, Cedric M Cunanan, Aubrey Manack Adams and Richard B. Lipton)
2015 – Trigger Point Injections for Headache Disorders: Expert Consensus Methodology and Narrative Review (Matthew S. Robbins, Deena Kuruvilla, Andrew Blumenfeld, Larry Charleston IV, Michael Sorrell, Carrie E. Robertson, Brian M. Grosberg, Steven D. Bender, Uri Napchan and Avi Ashkenazi)